Darwin Discovery Limited
90Patents
2Active
90Granted
37Portfolio score
Filing activity: Oct 27, 1995 → Oct 31, 2007 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6803453B1 | Antibodies associated with alterations in bone density | Physics | 86 | Expired |
| US6395511B1 | Nucleic acids encoding a novel family of TGF-&bgr; binding proteins from humans | Physics | 79 | Expired |
| US6495736B1 | Compositions and methods for increasing bone mineralization | Physics | 73 | Expired |
| US7192583B2 | Methods for modulating bone mineralization | Physics | 56 | Expired |
| US5849763A | Use of levobupivacaine as an anesthetic agent | Human Necessities | 45 | Expired |
| US6417201B1 | Levobupivacaine as an analgesic agent | Human Necessities | 44 | Expired |
| US6069151A | Quinolines and their therapeutic use | Emerging Cross-Sectional Technologies | 42 | Expired |
| US5955479A | Levobupivacaine for managing chronic pain | Human Necessities | 41 | Expired |
| US7758858B2 | Antibodies associated with alterations in bone density | Physics | 40 | Expired |
| US6133240A | Tetrahydronapthalene derivatives and their therapeutic use | Chemistry; Metallurgy | 38 | Expired |
| US5994548A | Crystallisation of levibupivacaine and analogues thereof | Chemistry; Metallurgy | 38 | Expired |
| US5910502A | Use of levobupivacaine in paediatric surgery | Human Necessities | 38 | Expired |
| US6384227B2 | Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents | Chemistry; Metallurgy | 37 | Expired |
| US5932597A | Anaesthetic formulation | Human Necessities | 37 | Expired |
| US6103741A | Analgesic agent and its use | Human Necessities | 31 | Expired |
| US6069155A | Levobupivacaine and its use | Human Necessities | 29 | Expired |
| US5945435A | Levobupivacaine and its use | Human Necessities | 29 | Expired |
| US5919804A | Use of levobupivacaine in facial surgery | Human Necessities | 28 | Expired |
| US6297286A | Therapeutic use and formulation | Human Necessities | 24 | Expired |
| US6118001A | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity | Chemistry; Metallurgy | 23 | Expired |
| US6566384B1 | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity | Chemistry; Metallurgy | 19 | Expired |
| US6048841A | Peptidyl compounds | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5955435A | Peptidyl compounds having MMP and TNF inhibitory activity | Chemistry; Metallurgy | 15 | Expired |
| US5972936A | Benzofuran carboxamides and their therapeutic use | Chemistry; Metallurgy | 14 | Expired |
| US6221394A | Dosage forms | Human Necessities | 13 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.